Hemabate Side Effects
Generic Name: carboprost
Note: This page contains information about the side effects of carboprost. Some of the dosage forms included on this document may not apply to the brand name Hemabate.
Not all side effects for Hemabate may be reported. You should always consult a doctor or healthcare professional for medical advice. Side effects can be reported to the FDA here.
For the Consumer
Applies to carboprost: intramuscular solution
Along with its needed effects, carboprost (the active ingredient contained in Hemabate) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.
Check with your doctor immediately if any of the following side effects occur while taking carboprost:Less common or rare
- Fast or slow heartbeat
- headache (severe and continuing)
- hives or skin rash
- increased pain of the uterus
- pale, cool, blotchy skin on arms or legs
- pressing or painful feeling in chest
- shortness of breath
- swelling of face, inside the nose, and eyelids
- tightness in chest
- trouble in breathing
- weak or absent pulse in arms or legs
Check with your doctor as soon as possible if any of the following side effects occur while taking carboprost:
- pain or inflammation at place of injection
- tender or mildly bloated abdomen or stomach
Some side effects of carboprost may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:More common
- Chills or shivering
- fever (temporary)
- flushing or redness of face
- stomach cramps or pain
This procedure may result in some effects, which occur after the procedure is completed, that need medical attention. Check with your doctor if you notice any of the following:
- Chills or shivering (continuing)
- fever (continuing)
- foul-smelling vaginal discharge
- increase in uterus bleeding
- pain in lower abdomen
For Healthcare Professionals
Applies to carboprost: injectable solution
-Contractile effect on smooth muscle, nausea, vomiting, diarrhea, increased temperature and flushing are the most frequent adverse reactions observed.
-Adverse effects of this drug are generally transient and reversible when therapy ends.
-Endometritis, retained placental fragments, and excessive uterine bleeding were the most common complications after discharge from the hospital.
Transient pyrexia may be due to the effect of carboprost on hypothalamic thermoregulation. Temperature elevation exceeding 2 degrees Fahrenheit have been reported in approximately 12.5% of the patients who received the recommended dosage regimen. In all cases, temperature returned to normal when therapy ended.
Pretreatment or concurrent administration of antiemetic and antidiarrheal drugs considerably decreases the very high incidence of gastrointestinal side effects that are common with all prostaglandins used for abortion.
Very common (10% or more): Vomiting and diarrhea (66%), nausea (33%)
Uncommon (0.1% to 1%): Hematemesis, upper abdominal pain, dry mouth
Frequency not reported: Epigastric pain, excessive thirst, taste alterations, gagging
Postmarketing reports: Retching
Very common (10% or more): Body temperature increased (12%)
Uncommon (0.1% to 1%): Vertigo, tinnitus
Frequency not reported: Retained placental fragment
Postmarketing reports: Chest pain, asthenia
The degree of hypertension was moderate and it is not certain as to whether it was due to a direct effect of carboprost (the active ingredient contained in Hemabate) or a return to a status of pregnancy associated hypertension manifested by the correction of hypovolemic shock.
Common (1% to 10%): Flushing, hot flushing, chills
Uncommon (0.1% to 1%): Septic shock, tachycardia
Frequency not reported: Hypertension, shivering
Postmarketing reports: Palpitations
When carboprost (the active ingredient contained in Hemabate) was used for abortion, the most common complications which required additional treatment after discharge from the hospital were endometritis, retained placental fragments, and excessive uterine bleeding which was reported to have occurred in approximately 2% of patients.
Common (1% to 10%): Endometritis, uterine hemorrhage, retained placenta or membranes
Uncommon (0.1% to 1%): Urinary tract infection, uterine rupture, uterine cervical laceration, pelvic pain
Frequency not reported: Dysmenorrhea-like pain, uterine disorder, perforated uterus, uterine sacculation, uterine rupture
Common (1% to 10%): Headaches
Uncommon (0.1% to 1%): Syncope vasovagal, dizziness, dystonia, paresthesia, somnolence, dysgeusia, lethargy
Frequency not reported: Drowsiness, faintness, lightheadedness
Postmarketing reports: Nervousness, syncope
Common (1% to 10%): Cough
Uncommon (0.1% to 1%): Asthma, respiratory distress, dyspnea, hyperventilation, wheezing, hiccups
Frequency not reported: Nosebleed, bronchospasm, pharyngeal edema, upper respiratory tract infection, pulmonary edema, shortness of breath, fullness of throat
Postmarketing reports: Chocking sensation, epistaxis, dry throat
Uncommon (0.1% to 1%): Hyperhidrosis
Frequency not reported: Diaphoresis
Postmarketing reports: Rash
Uncommon (0.1% to 1%): Injection side pain
Uncommon (0.1% to 1%): Torticollis, back pain, myalgia
Frequency not reported: Breast tenderness, muscular pain, muscle spasms, leg cramps
Postmarketing reports: Blepharospasm
Uncommon (0.1% to 1%): Blurred vision, eye pain
Frequency not reported: Twitching eyelids
Uncommon (0.1% to 1%): Sleep disorders
Postmarketing reports: Anxiety
Frequency not reported: Thyroid storm
Postmarketing reports: Thyrotoxic crisis
Postmarketing reports: Anaphylactic reactions, anaphylactic shock, anaphylactoid reaction, angioedema
More about Hemabate (carboprost)
Related treatment guides
Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This material does not endorse drugs, diagnose patients, or recommend therapy. This information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate safety, effectiveness, or appropriateness for any given patient. Drugs.com does not assume any responsibility for any aspect of healthcare administered with the aid of materials provided. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the substances you are taking, check with your doctor, nurse, or pharmacist.